Orrick Grows Life Sciences IP Licensing & Transactions Team

• Gina Marek joins Orrick’s Technology Transactions team as a partner in Silicon Valley.
• Gina advises emerging and high-growth companies on foundational inbound IP grants/rights, strategic collaborations and joint development arrangements, and bet-the-company IPR conveyances. She also represents investors in venture financings and exits.
• She focuses on clients at the intersection of life sciences and technology, with deep experience across pharmaceuticals, healthtech, software, hardware, e-commerce, internet and media.
• Gina joins from Gunderson Dettmer, where she served as Co-Chair of the Strategic Licensing & Transactions Group.
• Gina’s hire follows Orrick’s additions this year of NY tech companies advisor Agatha Kluk and former USPTO Solicitor Farheena Rasheed.

“We’re excited to build out our platform to deliver holistic solutions for the most disruptive companies in life sciences,” said Scott Iyama, Deputy Leader of Orrick’s global Corporate practice. “Gina is a recognized leader in this space, sought after by companies throughout their lifecycle.”

“I’ve spent my career delivering pragmatic legal advice tailored to founders’ needs, and I’m excited to be able to scale that practice on Orrick’s wide-reaching platform,” said Gina. “I’m thrilled to reconnect with many colleagues and join new ones to grow with this team.”

“Strategic IP and licensing transactions are essential to helping our company clients scale – now more than ever,” said Sarah Schaedler, Orrick’s Technology Transactions Group Leader. “We so look forward to collaborating with a top talent like Gina as we continue to grow our global technology transaction platform.”

Orrick has ranked top 5 globally for venture capital for eight years in a row (PitchBook) and ranked top 10 globally for M&A by deal volume in 2025 (LSEG).